Calidi Biotherapeutics Correlations

CLDI Stock

1.24 0.05 3.88%

The current 90-days correlation between Calidi Biotherapeutics and Can Fite Biopharma is 0.02 (i.e., Significant diversification). The correlation of Calidi Biotherapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Calidi Biotherapeutics Correlation With Market

Modest diversification

The correlation between Calidi Biotherapeutics and DJI is 0.21 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Calidi Biotherapeutics and DJI in the same portfolio, assuming nothing else is changed.

Build AI portfolio with Calidi Stock

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Calidi Biotherapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in small area income & poverty estimates.

For more detail on how to invest in Calidi Stock please use our How to Invest in Calidi Biotherapeutics guide.

Moving together with Calidi Stock

0.68	RAC	Race Oncology	Pair Corr
0.69	VALN	Valneva SE ADR	Pair Corr
0.72	DRMA	Dermata Therapeutics	Pair Corr
0.64	AVH	Avita Medical	Pair Corr
0.67	PYC	Physiomics Plc	Pair Corr
0.65	VINC	Vincerx Pharma, Common	Pair Corr
0.65	VIVS	VivoSim Labs, Symbol Change	Pair Corr
0.67	ALA	Arovella Therapeutics	Pair Corr
0.78	VRAX	Virax Biolabs Group	Pair Corr

Moving against Calidi Stock

0.64	DSGN	Design Therapeutics	Pair Corr
0.61	DVAX	Dynavax Technologies Trending	Pair Corr
0.6	VERA	Vera Therapeutics	Pair Corr
0.59	0P6S	Bayer AG NA	Pair Corr
0.56	VCYT	Veracyte	Pair Corr
0.55	DNTH	Dianthus Therapeutics	Pair Corr
0.55	DRUG	Bright Minds Biosciences	Pair Corr
0.48	DRTS	Alpha Tau Medical	Pair Corr
0.47	DMAC	DiaMedica Therapeutics	Pair Corr
0.42	VCEL	Vericel Corp Ord	Pair Corr
0.38	CDIOW	Cardio Diagnostics	Pair Corr
0.34	DNLI	Denali Therapeutics	Pair Corr
0.76	VTVT	vTv Therapeutics	Pair Corr
0.69	VRDN	Viridian Therapeutics	Pair Corr
0.62	VRTX	Vertex Pharmaceuticals	Pair Corr
0.62	ENTA	Enanta Pharmaceuticals	Pair Corr
0.58	VYNE	Vyne Therapeutics	Pair Corr
0.49	VNDA	Vanda Pharmaceuticals	Pair Corr

Related Correlations Analysis

	CMND	CANF	KZIA	TTNP	SILO	CNSP	SXTP	XBIO	QLGN	SNGX
CMND		0.91	-0.63	0.02	0.86	0.78	0.94	0.58	-0.24	0.18	CMND
CANF	0.91		-0.53	0.08	0.95	0.83	0.89	0.57	-0.39	0.15	CANF
KZIA	-0.63	-0.53		-0.25	-0.43	-0.4	-0.56	-0.34	-0.02	0.18	KZIA
TTNP	0.02	0.08	-0.25		0.0	-0.04	0.07	0.09	0.22	-0.21	TTNP
SILO	0.86	0.95	-0.43	0.0		0.83	0.82	0.55	-0.5	0.19	SILO
CNSP	0.78	0.83	-0.4	-0.04	0.83		0.81	0.76	-0.66	0.4	CNSP
SXTP	0.94	0.89	-0.56	0.07	0.82	0.81		0.67	-0.24	0.26	SXTP
XBIO	0.58	0.57	-0.34	0.09	0.55	0.76	0.67		-0.38	0.53	XBIO
QLGN	-0.24	-0.39	-0.02	0.22	-0.5	-0.66	-0.24	-0.38		-0.3	QLGN
SNGX	0.18	0.15	0.18	-0.21	0.19	0.4	0.26	0.53	-0.3		SNGX
	CMND	CANF	KZIA	TTNP	SILO	CNSP	SXTP	XBIO	QLGN	SNGX

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

SILO	+ 0.95	CANF
SXTP	+ 0.94	CMND
CANF	+ 0.91	CMND
SXTP	+ 0.89	CANF
SILO	+ 0.86	CMND
CNSP	+ 0.83	CANF

High negative correlations

QLGN	- 0.66	CNSP
KZIA	- 0.63	CMND
SXTP	- 0.56	KZIA
KZIA	- 0.53	CANF
QLGN	- 0.5	SILO
SILO	- 0.43	KZIA

Risk-Adjusted Indicators

There is a big difference between Calidi Stock performing well and Calidi Biotherapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Calidi Biotherapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
CMND	6.16	(3.60)	0.00	1.24	0.00	0.00	8.47	(21.84)	56.34
CANF	3.94	(1.40)	0.00	1.93	0.00	0.00	8.16	(8.11)	38.79
KZIA	6.76	0.09	0.05	0.09	7.99	(7.43)	12.48	(14.20)	73.49
TTNP	3.46	0.23	0.03	0.51	5.38	(3.74)	9.38	(8.08)	30.41
SILO	3.92	(1.31)	0.00	(0.28)	0.00	0.00	8.33	(9.09)	24.79
CNSP	3.09	(0.47)	0.00	(0.37)	0.00	0.00	5.99	(6.36)	18.23
SXTP	3.52	(0.96)	0.00	(1.16)	0.00	0.00	6.90	(7.45)	35.46
XBIO	6.84	0.20	0.04	0.15	7.30	(10.23)	4.96	(9.06)	174.58
QLGN	7.32	1.45	0.19	1.19	6.49	(10.05)	13.00	(10.32)	120.03
SNGX	4.56	(0.39)	0.00	(0.10)	0.00	0.00	10.37	(8.84)	38.79

Calidi Biotherapeutics Corporate Management

Andrew Jackson	Chief Officer	Profile
PharmD Santidrian	Head Officer	Profile
Stephen Thesing	Chief Officer	Profile
Thomas Herrmann	Managing Development	Profile
Wendy Esq	Chief Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC